IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2018 - 2021)
IDEAYA Biosciences (IDYA) reported Other Non-Current Liabilities of $6000.0 for Q3 2021, down 50.0% on a YoY basis from $12000.0 in Q3 2020, and little changed sequentially from $6000.0 in Q2 2021.
IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2018 - 2021) Analysis & Trends
IDEAYA Biosciences (IDYA) has 4 years of Other Non-Current Liabilities data on file, last reported at $6000.0 in Q3 2021.
- For the quarter ending Q3 2021, Other Non-Current Liabilities fell 50.0% year-over-year to $6000.0; the trailing twelve-month figure through Sep 2021 stood at $6000.0 (down 50.0% YoY), and the FY2020 full-year result was $12000.0, down 64.71% from the prior year.
- Other Non-Current Liabilities was little changed at $6000.0 in Q3 2021, from $6000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $113000.0 in Q4 2018 to a low of $6000.0 in Q2 2021.
- A 4-year average of $29142.9 and a median of $12000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities tumbled 69.91% in 2019 and slumped 50.0% in 2021, its largest moves.
- Tracing IDYA's Other Non-Current Liabilities over 4 years: stood at $113000.0 in 2018, then plunged by 69.91% to $34000.0 in 2019, then sank by 64.71% to $12000.0 in 2020, then tumbled by 50.0% to $6000.0 in 2021.
- Business Quant data shows IDYA's Other Non-Current Liabilities at $6000.0 in Q3 2021, $6000.0 in Q2 2021, and $12000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Dec 31, 2020 | 12,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Dec 31, 2019 | 34,000.00 |
| Dec 31, 2018 | 113,000.00 |